tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ocular Therapeutix price target raised to $19 from $15 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Ocular Therapeutix (OCUL) to $19 from $15 and keeps a Buy rating on the shares. The firm updated the company’s model with potential sales of Axpaxli in non-proliferative diabetic retinopathy.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1